CVSI News and Press, CV Sciences Inc.

2024-05-14 14:10:24 ET CV Sciences, Inc. (CVSI) Q1 2024 Earnings Conference Call May 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants Presentation Operator ...

2024-05-14 09:09:46 ET More on CV Sciences CV Sciences acquires Elevated Softgels Financial information for CV Sciences Read the full article on Seeking Alpha For further details see: CV Sciences Non-GAAP EPS of $0.00, revenue of $4M

CV Sciences, Inc. Reports First Quarter 2024 Financial Results PR Newswire SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...

2024-05-14 04:37:24 ET More on CV Sciences CV Sciences, Inc. (CVSI) Q4 2023 Earnings Call Transcript Financial information for CV Sciences Read the full article on Seeking Alpha For further details see: CV Sciences acquires Elevated Softgels

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER PR Newswire SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer we...

CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024 PR Newswire SAN DIEGO , May 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company special...

2024-03-28 13:52:51 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips CV Sciences (OTCMKTS: CVSI ) just reported results for the fourth quarter of 2023. CV Sciences reported earnings per share of -1 cent. The company reported revenue of ...

2024-03-28 11:42:07 ET CV Sciences, Inc. (CVSI) Q4 2023 Earnings Conference Call March 28, 2024, 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg Grasser - Chief Financial Officer Presentat...

2024-03-28 09:09:43 ET More on CV Sciences Financial information for CV Sciences Read the full article on Seeking Alpha For further details see: CV Sciences Non-GAAP EPS of -$0.02, revenue of $16M

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results PR Newswire SAN DIEGO , March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...